HUADONG MEDICINE
Huadong Medicine is mainly engaged in the production and sales of antibiotics, proprietary Chinese medicines, chemical synthetic drugs
HUADONG MEDICINE
Industry:
Biotechnology Emergency Medicine Health Care Manufacturing
Founded:
1993-03-31
Status:
Active
Technology used in webpage:
Content Delivery Network Nginx DigiCert SSL RapidSSL Apache Tomcat Coyote Baidu Maps AliDNS
Similar Organizations
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Micro Biotech
Micro Biotech focuses on the discovery, testing, production, and sales of novel antibacterial, antiviral, and antibacterial drugs.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-05-27 | Jolly Pharmaceutical | Jolly Pharmaceutical acquired by Huadong Medicine | 1.06 B CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-27 | Ashvattha Therapeutics | Huadong Medicine investment in Series B - Ashvattha Therapeutics | 69 M USD |
| 2022-02-28 | Heidelberg Pharma AG | Huadong Medicine investment in Post-IPO Equity - Heidelberg Pharma AG | 105 M EUR |
| 2021-02-03 | R2 Technologies | Huadong Medicine investment in Series B - R2 Technologies | 10 M USD |
| 2020-04-23 | R2 Technologies | Huadong Medicine investment in Series B - R2 Technologies | 10 M USD |
| 1993-11-10 | NINGBO DONGHAI BANK | Huadong Medicine investment in Angel Round - NINGBO DONGHAI BANK | 3 M CNY |
More informations about "Huadong Medicine"
Huadong Medicine - Wikipedia
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share …See details»
Huadong Medicine - Crunchbase Investor Profile & Investments
Huadong Medicine is a pharmaceutical company. They engage in the research and development, production, and sales of specialty medicines, chronic disease medicines, and other medicines. …See details»
Huadong Medicine - eastchinapharm.com
Mr.Lv Liang,of Han nationality,was born in August 1974.Mr. Lv started his career since July 1997 with the master’s degree in Business Administration and joined Huadong Medicine Co.,Ltd. in …See details»
Huadong Medicine - CGE - cgeinc.com
Huadong Medicine Co., Ltd. (000963.SZ), headquartered in Hangzhou City, Zhejiang Province, was listed on the Shenzhen Stock Exchange in December 1999. Recognized by Forbes as …See details»
Huadong Medicine - Investments, Portfolio & Company Exits
Huadong Medicine is a manufacturer and seller of antibiotics, proprietary Chinese medicines, and synthetic drugs. New. Resources. Advanced Search. Start Free Trial . ... How many …See details»
Huadong Medicine (SHE:000963) Company Profile & Description
4 days ago Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through …See details»
Huadong Medicine (Hangzhou) Biological Products Co., Ltd.
Find company research, competitor information, contact details & financial data for Huadong Medicine (Hangzhou) Biological Products Co., Ltd. of Hangzhou, Zhejiang. Get the latest …See details»
Huadong Medicine - businessabc.net
Feb 18, 2025 Huadong Medicine Company was established in 1980 and since then has grown to be a major player in the Chinese pharmaceutical industry. We have consistently launched …See details»
Huadong Medicine Seeks Regular Approval for Elahere in Ovarian …
Mar 11, 2025 China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that its application for converting conditional to regular approval for Elahere (mirvetuximab …See details»
Huadong Medicine Co., Ltd. and SynerK reached a strategic …
About Huadong Medicine Co., Ltd. Huadong Medicine Co., Ltd. (stock code: 000963.SZ) was founded in 1993 and is headquartered in Hangzhou, Zhejiang. The company adheres to the …See details»
Huadong Medicine (Xi\'an) Bodyguard Pharmaceutical Co., Ltd.
Find company research, competitor information, contact details & financial data for Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co., Ltd. of Huayin, Shaanxi. Get the latest …See details»
Huadong Medicine Co Ltd Executive & Employee Information
The following section provides information on Huadong Medicine Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight …See details»
Huadong Medicine's reinvestment in botulinum toxin products
Feb 12, 2025 According to Huadong Medicine's announcement, in the first three quarters of this year, the overall medical aesthetics sector achieved a total operating income of 1.874 billion …See details»
HDM-2020 - Drug Targets, Indications, Patents - Synapse
Feb 17, 2025 HDM-2020, Initially developed by Huadong Medicine Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication ...See details»
Huadong Medicine’s HDM1005 Shows Positive Results in Phase …
Feb 18, 2025 China-based Huadong Medicine Co., Ltd (SHE: 000963) announced positive results from the Phase Ia/Ib study of HDM1005, a long-acting agonist targeting the GLP-1 and …See details»
Huadong Medicine Co., Ltd. and SynerK reached a strategic …
Dec 30, 2024 About Huadong Medicine Co., Ltd. Huadong Medicine Co., Ltd. (stock code: 000963.SZ) was founded in 1993 and is headquartered in Hangzhou, Zhejiang. The company …See details»
Huadong Medicine and Insilico Medicine enter co-development …
Sep 8, 2021 In addition, Huadong Medicine's R&D organization currently has more than 1000 FTEs involved in drug discovery, preclinical research, clinical research, CMC, and RA. …See details»
Huadong Medicine XSEC:000963 Stock Report - Simply Wall St
6 days ago Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through …See details»
Huadong buys into Heidelberg, signs nearly $1B deal to gain …
Feb 28, 2022 Huadong Medicine will invest about $118 million for a 35% stake in Heidelberg Pharma plus dole out up to $930 million in a licensing deal for four oncology assets.See details»
How AI is transforming medicine — Harvard Gazette
2 days ago BERNARD CHANG: What most excites me about AI’s promise in medicine is that these technological tools will allow physicians to spend more time on the human aspects of the …See details»